The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gilmartin Geoffrey S. since 2019.
The trader's CIK number is 1688268.
At the time of the last reporting, Gilmartin Geoffrey S. was the Chief Development Officer of Proteostasis Therapeutics, Inc.. (stock ticker symbol PTI).
Also see all insider trading activities at Proteostasis Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | PTI | 0 | $0 | 9,189 | $27,484 | 24,100 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-01 | PTI | Option Ex | 24,100 | .00 | 0 |
| 2019-02-04 | PTI | Sale | 9,189 | 2.99 | 27,484 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gilmartin Geoffrey S. (Chief Development Officer of Proteostasis Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.